IMVTImmunovant, Inc.

$30.48+106% 1Y

What is the market doing?

Mixed

No clear lean: rangebound and insiders net selling (often routine).

3 neutral
TrendRangeboundderived · Oct 9, 2026

Rangebound, no clear trend. Oversold (RSI 9). Price is −1% vs its 200-day average.

Insider conviction−$856K (90 days to Oct 8, 2026)SEC EDGAR · Oct 8, 2026

Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).

Short interest8.5% of sharesFINRA · Sep 15, 2026

Heavily shorted, settled Sep 15, 2026, more than a week of normal trading to cover, a crowded exit.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

1-year returntop 7% of the market
vs 200-day avgmiddle of the market

Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.

How IMVT is trading

Immunovant, Inc. is +106% over the past year while the S&P 500 is +18%: 88 points ahead of the market.

+106%

1-year return · S&P 500 +18%

vs 200-day average
−1.4%

vs 200-day average · below trend, but not far

RSI (14)
9

RSI (14) · oversold, sold harder than it has been bought

Below its 52-week high
32%

Below its 52-week high

Sep 18, 2024$13.31 – $45.00 · dashed line: 200-day averageOct 9, 2026
Details›
Last close2026-10-09
$30.48
1 monthS&P 500 +2.7%
−20%
1 yearS&P 500 +18%
+106%
5 yearsS&P 500 +88%
+259%
vs 50-day average$38.32
−20%
52-week high
$45.00
52-week low
$14.90
Annualised volatility
57%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
−$13M
Calendar-year price return
YearReturn
2026 (year to date)+20%
2025+2.6%
2024−41%
2023+137%
2022+108%
2021−82%
2020+191%
Average return by calendar month, 2019–2026
MonthYearsPositiveAverage
Jan72 of 7−8.2%
Feb71 of 7−12%
Mar71 of 7−6.9%
Apr73 of 7−0.94%
May73 of 7+9.2%
Jun73 of 7−3.8%
Jul85 of 8+3.8%
Aug85 of 8+7.6%
Sep86 of 8+8.4%
Oct85 of 8+19%
Nov74 of 7+5.9%
Dec75 of 7+13%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.